DNA Repair refers to the collection of molecular mechanisms that detect, remove, tolerate or correct damage and replication errors affecting DNA. DNA is chemically stable compared with many biological molecules but is continuously exposed to spontaneous chemical changes and environmental sources of damage. Examples include base modifications, abasic sites, single strand breaks, double strand breaks, bulky chemical adducts, ultraviolet induced lesions, oxidative damage and mismatched bases generated during replication.
Different forms of damage require different repair pathways because the chemical structures and risks associated with the lesions vary. Repair systems generally involve damage recognition, processing of the affected DNA, restoration of the correct sequence or structure and, in many cases, verification. The overall purpose is to preserve genome integrity while allowing cells to tolerate unavoidable chemical and physical challenges.
One major class of DNA Repair is base excision repair, which primarily addresses relatively small lesions that do not substantially distort the DNA helix. DNA glycosylases recognise particular damaged or inappropriate bases and cleave the bond connecting the base to the sugar, creating an abasic site. Additional enzymes process the resulting site, remove damaged sugar phosphate material and insert the appropriate nucleotide. DNA polymerase and DNA ligase then restore the DNA backbone.
Different glycosylases have different substrate preferences, allowing cells to recognise oxidative damage, deamination products and other chemically altered bases. The pathway illustrates an important principle of repair biology: cells do not use one universal repair mechanism but deploy specialised enzymes according to the chemical nature of the lesion.
Nucleotide excision repair addresses bulky DNA lesions that distort the double helix. In this pathway, proteins recognise structural distortion, locally unwind the DNA and excise a short oligonucleotide containing the damaged region. The resulting gap is filled using the undamaged complementary strand as a template, followed by ligation. Nucleotide excision repair is particularly important for lesions produced by ultraviolet radiation and certain chemical compounds.
In humans, defects in components of this pathway can cause disorders characterised by extreme sensitivity to ultraviolet exposure and increased cancer susceptibility. Transcription coupled repair represents a specialised form in which damage that blocks transcription machinery is recognised preferentially, helping restore the ability of actively transcribed genes to be expressed. This illustrates how DNA Repair is connected to gene expression as well as genome integrity.
Mismatch repair corrects errors that escape the proofreading activity of DNA polymerases during replication. Such errors include incorrect base pairings and small insertion or deletion loops. The system identifies the mismatch, determines which newly synthesised strand contains the error and removes a segment containing the incorrect nucleotide. DNA synthesis and ligation then restore the sequence using the parental strand as a template.
In bacteria, strand discrimination can involve specific methylation patterns, while eukaryotic systems use different mechanisms associated with replication machinery and newly synthesised DNA. Defects in mismatch repair can produce microsatellite instability and increase susceptibility to particular cancers. Mismatch repair therefore acts as an important second layer of replication fidelity and demonstrates that genome maintenance extends beyond the immediate proofreading capacity of DNA polymerases.
Double strand breaks are particularly hazardous because both DNA strands are interrupted and an intact complementary strand is not directly available across the break. Homologous recombination can repair such breaks using a homologous DNA molecule as a template and can therefore provide high fidelity under appropriate circumstances. Non homologous end joining instead reconnects broken DNA ends with limited requirement for an extensive homologous template and can operate efficiently in many cell types.
Alternative end joining mechanisms also exist and can be more error prone. The choice and availability of repair pathways depend on cell cycle state, chromosome context and the nature of the break. Repair of double strand breaks is therefore intimately connected with chromosome rearrangements, mutation and cancer biology. Incorrect repair can generate deletions, insertions, translocations or other structural alterations.
DNA damage responses involve more than direct repair chemistry. Cells can detect damage and activate signalling pathways that alter cell cycle progression, transcription, replication and apoptosis. Protein kinases and checkpoint systems can temporarily halt progression through the cell cycle, providing time for repair. If damage is too extensive, cells may enter senescence or undergo programmed cell death. Replication forks encountering lesions can also trigger specialised tolerance mechanisms that allow replication to continue, sometimes at the cost of increased mutation.
The distinction between repair and damage tolerance is important because not every pathway removes the original lesion immediately. Some pathways allow replication or transcription to proceed despite damage, while later mechanisms can resolve the resulting structures. Genome maintenance is therefore a network involving direct repair, checkpoint signalling, replication control and cellular fate decisions.
DNA Repair has major medical significance because persistent DNA damage and defective repair can contribute to mutation, cancer, neurodegeneration, premature ageing phenotypes and inherited repair disorders. Certain anticancer treatments deliberately create DNA damage or inhibit repair pathways so that tumour cells cannot maintain viable genomes. The effectiveness of such treatments can depend on the specific repair deficiencies of tumour cells. Genetic defects in repair proteins can also create characteristic disease risks. For example, defects in mismatch repair can predispose to particular hereditary cancer syndromes, while defects in nucleotide excision repair can cause severe sensitivity to ultraviolet radiation. These relationships have encouraged precision medicine approaches that consider tumour genotype and repair pathway status when selecting treatments.
DNA Repair is not perfectly accurate in every circumstance, and some damage can become permanent mutation. Repair itself can occasionally introduce errors, particularly when specialised polymerases or alternative end joining pathways are involved. Repair pathways can also compete with one another or operate differently depending on cellular context. A further misconception is that every DNA lesion must be repaired before a cell can function. Cells instead balance repair, tolerance, checkpoint activation and elimination.
Some DNA modifications are temporary or biologically regulated rather than accidental damage, while others are genuinely harmful lesions. Effective repair requires accurate lesion recognition and appropriate pathway selection. The overall significance of DNA Repair is therefore not simply restoration of an ideal DNA sequence but controlled management of genome damage in a way that preserves cellular viability while limiting harmful mutation and chromosome instability.
